Page last updated: 2024-10-21

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Amyotrophic Lateral Sclerosis

1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine has been researched along with Amyotrophic Lateral Sclerosis in 8 studies

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A dopaminergic neurotoxic compound which produces irreversible clinical, chemical, and pathological alterations that mimic those found in Parkinson disease.
1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine : A tetrahydropyridine that is 1,2,3,6-tetrahydropyridine substituted by a methyl group at position 1 and a phenyl group at position 4.

Amyotrophic Lateral Sclerosis: A degenerative disorder affecting upper MOTOR NEURONS in the brain and lower motor neurons in the brain stem and SPINAL CORD. Disease onset is usually after the age of 50 and the process is usually fatal within 3 to 6 years. Clinical manifestations include progressive weakness, atrophy, FASCICULATION, hyperreflexia, DYSARTHRIA, dysphagia, and eventual paralysis of respiratory function. Pathologic features include the replacement of motor neurons with fibrous ASTROCYTES and atrophy of anterior SPINAL NERVE ROOTS and corticospinal tracts. (From Adams et al., Principles of Neurology, 6th ed, pp1089-94)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19901 (12.50)18.7374
1990's2 (25.00)18.2507
2000's3 (37.50)29.6817
2010's1 (12.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Lee, JD1
Woodruff, TM1
Chen, X1
Wales, P1
Quinti, L1
Zuo, F1
Moniot, S1
Herisson, F1
Rauf, NA1
Wang, H1
Silverman, RB1
Ayata, C1
Maxwell, MM1
Steegborn, C1
Schwarzschild, MA1
Outeiro, TF1
Kazantsev, AG1
Vila, M2
Przedborski, S2
Choi, DK1
Pennathur, S1
Perier, C1
Tieu, K1
Teismann, P1
Wu, DC1
Jackson-Lewis, V1
Vonsattel, JP1
Heinecke, JW1
Edwards, RH1
Andreassen, OA1
Ferrante, RJ1
Klivenyi, P1
Klein, AM1
Dedeoglu, A1
Albers, DS1
Kowall, NW1
Beal, MF1
Tanner, CM1
Langston, JW1
Uhl, GR1
Javitch, JA1
Snyder, SH1

Reviews

3 reviews available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Amyotrophic Lateral Sclerosis

ArticleYear
Targeting programmed cell death in neurodegenerative diseases.
    Nature reviews. Neuroscience, 2003, Volume: 4, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Anim

2003
Neural degeneration and the transport of neurotransmitters.
    Annals of neurology, 1993, Volume: 34, Issue:5

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amyotrophic Lateral Sclerosis; Animals; Biological Tra

1993
Do environmental toxins cause Parkinson's disease? A critical review.
    Neurology, 1990, Volume: 40, Issue:10 Suppl 3

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Age Factors; Amyotrophic Lateral Sclerosis; Environmen

1990

Other Studies

5 other studies available for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine and Amyotrophic Lateral Sclerosis

ArticleYear
TDP-43 Puts the STING in ALS.
    Trends in neurosciences, 2021, Volume: 44, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amyotrophic Lateral Sclerosis; Bites and Stings; DNA-B

2021
The sirtuin-2 inhibitor AK7 is neuroprotective in models of Parkinson's disease but not amyotrophic lateral sclerosis and cerebral ischemia.
    PloS one, 2015, Volume: 10, Issue:1

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; alpha-Synuclein; Amyotrophic Lateral Sclerosis; Animal

2015
Ablation of the inflammatory enzyme myeloperoxidase mitigates features of Parkinson's disease in mice.
    The Journal of neuroscience : the official journal of the Society for Neuroscience, 2005, Jul-13, Volume: 25, Issue:28

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Amyotrophic Lateral Sclerosis; Animals; Brain; Corpus

2005
Transgenic ALS mice show increased vulnerability to the mitochondrial toxins MPTP and 3-nitropropionic acid.
    Experimental neurology, 2001, Volume: 168, Issue:2

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; 3,4-Dihydroxyphenylacetic Acid; Amyotrophic Lateral Sc

2001
Normal MPTP binding in parkinsonian substantial nigra: evidence for extraneuronal toxin conversion in human brain.
    Lancet (London, England), 1985, Apr-27, Volume: 1, Issue:8435

    Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Aged; Amyotrophic Lateral Sclerosis; Autoradiography;

1985